| __timestamp | MorphoSys AG | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 55962693 | 31354781 |
| Thursday, January 1, 2015 | 78655788 | 43445817 |
| Friday, January 1, 2016 | 95723069 | 66489820 |
| Sunday, January 1, 2017 | 116808575 | 96886134 |
| Monday, January 1, 2018 | 106397017 | 153793000 |
| Tuesday, January 1, 2019 | 108431600 | 148369000 |
| Wednesday, January 1, 2020 | 141426832 | 151934000 |
| Friday, January 1, 2021 | 225200000 | 198532000 |
| Saturday, January 1, 2022 | 297812160 | 112128000 |
| Sunday, January 1, 2023 | 283614139 | 76192000 |
Data in motion
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, MorphoSys AG and TG Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments.
MorphoSys AG has consistently increased its R&D spending, peaking in 2022 with a remarkable 433% increase from 2014. This upward trend underscores the company's strategic focus on expanding its therapeutic pipeline.
TG Therapeutics, Inc. showed a more volatile pattern, with a significant surge in 2018, where R&D expenses nearly quintupled compared to 2014. However, by 2023, their spending had decreased by 62% from its 2021 peak, reflecting potential strategic pivots or financial constraints.
These trends highlight the dynamic nature of biotech investments, where strategic decisions are often reflected in R&D allocations.
Research and Development: Comparing Key Metrics for Pfizer Inc. and MorphoSys AG
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and MorphoSys AG
TG Therapeutics, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
TG Therapeutics, Inc. or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: TG Therapeutics, Inc. vs Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: TG Therapeutics, Inc. and Dynavax Technologies Corporation
R&D Spending Showdown: CRISPR Therapeutics AG vs MorphoSys AG
Xenon Pharmaceuticals Inc. or MorphoSys AG: Who Invests More in Innovation?
Analyzing R&D Budgets: MorphoSys AG vs MannKind Corporation